EMEA-003084-PIP03-22 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Neurology
PIP number: P/0044/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Age-appropriate oral dosage formulation
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Ivozall
clofarabine
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation:
Revision: 5
Last updated:
MedicineHumanWithdrawn
Evoltra
clofarabine
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation:
Revision: 33
Last updated:
MedicineHumanAuthorised